{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:01:16Z","timestamp":1780617676977,"version":"3.54.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,4]]},"DOI":"10.7759\/cureus.110264","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T23:01:25Z","timestamp":1780614085000},"source":"Crossref","is-referenced-by-count":0,"title":["Sweet Syndrome in a Patient With Acute Myeloid Leukemia: A Diagnostic Challenge in the Setting of Chemotherapy-Induced Neutropenia"],"prefix":"10.7759","author":[{"given":"Azza","family":"Abdalla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasdeep S","family":"Bajwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1964.tb14541.x","article-title":"An acute febrile neutrophilic dermatosis","volume":"76","author":"Sweet RD","year":"1964","unstructured":"Sweet RD. An acute febrile neutrophilic dermatosis. Br J Dermatol. 1964, 76:349-56. 10.1111\/j.1365-2133.1964.tb14541.x","journal-title":"Br J Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.13350","article-title":"Sweet's syndrome: diagnostic criteria revisited","volume":"15","author":"Nofal A","year":"2017","unstructured":"Nofal A, Abdelmaksoud A, Amer H, et al.. Sweet's syndrome: diagnostic criteria revisited. J Dtsch Dermatol Ges. 2017, 15:1081-8. 10.1111\/ddg.13350","journal-title":"J Dtsch Dermatol Ges"},{"key":"ref3","article-title":"Diagnostic criteria for Sweet's syndrome","volume":"37","author":"Su WP","year":"1986","unstructured":"Su WP, Liu HN. Diagnostic criteria for Sweet's syndrome. Cutis. 1986 , 37:167-74.","journal-title":"Cutis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/s0190-9622(94)70215-2","article-title":"Sweet's syndrome (acute febrile neutrophilic dermatosis)","volume":"31","author":"von den Driesch P","year":"1994","unstructured":"von den Driesch P. Sweet's syndrome (acute febrile neutrophilic dermatosis). J Am Acad Dermatol. 1994, 31:535-56. 10.1016\/s0190-9622(94)70215-2","journal-title":"J Am Acad Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-2-34","article-title":"Sweet's syndrome--a comprehensive review of an acute febrile neutrophilic dermatosis","volume":"2","author":"Cohen PR","year":"2007","unstructured":"Cohen PR. Sweet's syndrome--a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis. 2007, 2:34. 10.1186\/1750-1172-2-34","journal-title":"Orphanet J Rare Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/ced.12899","article-title":"Sweet syndrome: long-term follow-up of 138 patients","volume":"41","author":"Marcoval J","year":"2016","unstructured":"Marcoval J, Mart\u00edn-Callizo C, Valent\u00ed-Medina F, Bonfill-Ort\u00ed M, Mart\u00ednez-Molina L. Sweet syndrome: long-term follow-up of 138 patients. Clin Exp Dermatol. 2016, 41:741-6. 10.1111\/ced.12899","journal-title":"Clin Exp Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.09.013","article-title":"Sweet syndrome in patients with and without malignancy: a retrospective analysis of 83 patients from a tertiary academic referral center","volume":"78","author":"Nelson CA","year":"2018","unstructured":"Nelson CA, Noe MH, McMahon CM, et al.. Sweet syndrome in patients with and without malignancy: a retrospective analysis of 83 patients from a tertiary academic referral center. J Am Acad Dermatol. 2018, 78:303-309.e4. 10.1016\/j.jaad.2017.09.013","journal-title":"J Am Acad Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-020-00553-9","article-title":"Immune-mediated dermatoses in patients with haematological malignancies: a comprehensive review","volume":"21","author":"Maglie R","year":"2020","unstructured":"Maglie R, Genovese G, Solimani F, et al.. Immune-mediated dermatoses in patients with haematological malignancies: a comprehensive review. Am J Clin Dermatol. 2020, 21:833-54. 10.1007\/s40257-020-00553-9","journal-title":"Am J Clin Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-022-00673-4","article-title":"New practical aspects of Sweet syndrome","volume":"23","author":"Joshi TP","year":"2022","unstructured":"Joshi TP, Friske SK, Hsiou DA, Duvic M. New practical aspects of Sweet syndrome. Am J Clin Dermatol. 2022, 23:301-18. 10.1007\/s40257-022-00673-4","journal-title":"Am J Clin Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.142.9.1170","article-title":"Chronic recurrent lymphocytic Sweet syndrome as a predictive marker of myelodysplasia: a report of 9 cases","volume":"142","author":"Vignon-Pennamen MD","year":"2006","unstructured":"Vignon-Pennamen MD, Juillard C, Rybojad M, et al.. Chronic recurrent lymphocytic Sweet syndrome as a predictive marker of myelodysplasia: a report of 9 cases. Arch Dermatol. 2006, 142:1170-6. 10.1001\/archderm.142.9.1170","journal-title":"Arch Dermatol"},{"key":"ref11","article-title":"Acute febrile neutrophilic dermatosis","author":"Majmundar VD","year":"2024","unstructured":"Majmundar VD, Saleh HM, Baxi K. Acute febrile neutrophilic dermatosis. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.140.5.570","article-title":"Elevated serum granulocyte colony-stimulating factor levels in patients with active phase of sweet syndrome and patients with active behcet disease: implication in neutrophil apoptosis dysfunction","volume":"140","author":"Kawakami T","year":"2004","unstructured":"Kawakami T, Ohashi S, Kawa Y, Takahama H, Ito M, Soma Y, Mizoguchi M. Elevated serum granulocyte colony-stimulating factor levels in patients with active phase of sweet syndrome and patients with active behcet disease: implication in neutrophil apoptosis dysfunction. Arch Dermatol. 2004, 140:570-4. 10.1001\/archderm.140.5.570","journal-title":"Arch Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00414","article-title":"Insights into the pathogenesis of Sweet's syndrome","volume":"10","author":"Heath MS","year":"2019","unstructured":"Heath MS, Ortega-Loayza AG. Insights into the pathogenesis of Sweet's syndrome. Front Immunol. 2019, 10:414. 10.3389\/fimmu.2019.00414","journal-title":"Front Immunol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae487","article-title":"The heterogeneous syndrome of noninfectious causes of persistent fever in neutropenic patients with hematologic malignancy: another opportunity for stewardship?","volume":"79","author":"Aslan AT","year":"2024","unstructured":"Aslan AT, Akova M, Kontoyiannis DP. The heterogeneous syndrome of noninfectious causes of persistent fever in neutropenic patients with hematologic malignancy: another opportunity for stewardship?. Clin Infect Dis. 2024, 79:1333-7. 10.1093\/cid\/ciae487","journal-title":"Clin Infect Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2012.09.005","article-title":"Sweet's syndrome: a revisit for hematologists and oncologists","volume":"86","author":"Paydas S","year":"2013","unstructured":"Paydas S. Sweet's syndrome: a revisit for hematologists and oncologists. Crit Rev Oncol Hematol. 2013, 86:85-95. 10.1016\/j.critrevonc.2012.09.005","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2014.12.009","article-title":"Characteristics of Sweet syndrome in patients with acute myeloid leukemia","volume":"15","author":"Kazmi SM","year":"2015","unstructured":"Kazmi SM, Pemmaraju N, Patel KP, et al.. Characteristics of Sweet syndrome in patients with acute myeloid leukemia. Clin Lymphoma Myeloma Leuk. 2015, 15:358-63. 10.1016\/j.clml.2014.12.009","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2004.06007.x","article-title":"Neutrophil-dependent cutaneous side-effects of leucocyte colony-stimulating factors: manifestations of a neutrophil recovery syndrome?","volume":"150","author":"Dereure O","year":"2004","unstructured":"Dereure O, Hillaire-Buys D, Guilhou JJ. Neutrophil-dependent cutaneous side-effects of leucocyte colony-stimulating factors: manifestations of a neutrophil recovery syndrome?. Br J Dermatol. 2004, 150:1228-30. 10.1111\/j.1365-2133.2004.06007.x","journal-title":"Br J Dermatol"},{"key":"ref18","article-title":"Sweet syndrome","author":"Vashisht P","year":"2022","unstructured":"Vashisht P, Goyal A, Holmes MPH. Sweet syndrome. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2022. 965-71."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2018.12.006","article-title":"The rash with painful and erythematous nodules","volume":"37","author":"Inamadar AC","year":"2019","unstructured":"Inamadar AC, Adya KA. The rash with painful and erythematous nodules. Clin Dermatol. 2019, 37:129-35. 10.1016\/j.clindermatol.2018.12.006","journal-title":"Clin Dermatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2024-260106","article-title":"Decitabine-induced Sweet syndrome","volume":"17","author":"Krishnasamy S","year":"2024","unstructured":"Krishnasamy S, Paul AA. Decitabine-induced Sweet syndrome. BMJ Case Rep. 2024, 17:10.1136\/bcr-2024-260106","journal-title":"BMJ Case Rep"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21510","article-title":"Atypical presentations of Sweet's syndrome in patients with MDS\/AML receiving combinations of hypomethylating agents with histone deacetylase inhibitors","volume":"84","author":"Alencar C","year":"2009","unstructured":"Alencar C, Abramowtiz M, Parekh S, Braunshweig I, Jacobson M, Silverman L, Verma A. Atypical presentations of Sweet's syndrome in patients with MDS\/AML receiving combinations of hypomethylating agents with histone deacetylase inhibitors. Am J Hematol. 2009, 84:688-9. 10.1002\/ajh.21510","journal-title":"Am J Hematol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2012.1861","article-title":"Histiocytoid Sweet's syndrome potentially related to decitabine in a patient with myelodysplastic syndrome","volume":"22","author":"Park JY","year":"2012","unstructured":"Park JY, Park JS, Kim YC. Histiocytoid Sweet's syndrome potentially related to decitabine in a patient with myelodysplastic syndrome. Eur J Dermatol. 2012, 22:811-2. 10.1684\/ejd.2012.1861","journal-title":"Eur J Dermatol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1973.tb01741.x","article-title":"Phagocytic function of leucocytes from patients with acute myeloid and chronic granulocytic leukaemia","volume":"25","author":"Goldman JM","year":"1973","unstructured":"Goldman JM, Th'ng KH. Phagocytic function of leucocytes from patients with acute myeloid and chronic granulocytic leukaemia. Br J Haematol. 1973, 25:299-308. 10.1111\/j.1365-2141.1973.tb01741.x","journal-title":"Br J Haematol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01336-x","article-title":"ASXL1\/2 mutations and myeloid malignancies","volume":"15","author":"Medina EA","year":"2022","unstructured":"Medina EA, Delma CR, Yang FC. ASXL1\/2 mutations and myeloid malignancies. J Hematol Oncol. 2022, 15:127. 10.1186\/s13045-022-01336-x","journal-title":"J Hematol Oncol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.12.037","article-title":"TET2-mediated clonal hematopoiesis accelerates heart failure through a mechanism involving the IL-1\u03b2\/NLRP3 inflammasome","volume":"71","author":"Sano S","year":"2018","unstructured":"Sano S, Oshima K, Wang Y, et al.. TET2-mediated clonal hematopoiesis accelerates heart failure through a mechanism involving the IL-1\u03b2\/NLRP3 inflammasome. J Am Coll Cardiol. 2018, 71:875-86. 10.1016\/j.jacc.2017.12.037","journal-title":"J Am Coll Cardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/465904-sweet-syndrome-in-a-patient-with-acute-myeloid-leukemia-a-diagnostic-challenge-in-the-setting-of-chemotherapy-induced-neutropenia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T23:01:26Z","timestamp":1780614086000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/465904-sweet-syndrome-in-a-patient-with-acute-myeloid-leukemia-a-diagnostic-challenge-in-the-setting-of-chemotherapy-induced-neutropenia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.110264","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,4]]}}}